Platelet and Thrombosis Research L.L.C Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Baltimore MD United States (2000)

Organization Overview

First Clinical Trial
2006
NCT00370045
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Platelet Thrombosis Research, LLC

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiovascular Diseases (Phase 1)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 2)

Infarction (Phase 4)

Myocardial Infarction (Phase 4)

Myocardial Ischemia (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 5